425: Strive CMO Reposts Semler Scientific Merger Update

Strive's Chief Marketing Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Summary

• A communication was reposted on X.com by Arshia Sarkhani, Chief Marketing Officer of Strive, Inc., on November 10, 2025.
• The communication is in connection with Strive's proposed business combination with Semler Scientific, Inc.
• The filing includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties related to the transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus when available for important information.
• Strive, Semler Scientific, and certain of their directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• This communication does not constitute an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 6

Explanation: The filing announces a proposed merger, which is generally a growth-oriented event. However, it is heavily weighted with extensive cautionary statements and a comprehensive list of risks, balancing the overall sentiment towards a neutral-to-slightly-positive outlook, pending further details.

Positives

• The proposed transaction aims for strategic and financial benefits for the combined company.
• Anticipated positive impact on the combined company's future financial performance.
• Expected cost savings and strategic gains are projected from the business combination.

Negatives

• Integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may incur higher expenses or take longer to complete than expected due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and other opportunities.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction could cause dilution.
• Potential adverse reactions from customers of Strive or Semler Scientific, or changes to business or employee relationships, may occur.
• Changes in Strive's or Semler Scientific's share price before the closing of the transaction are possible.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated due to various events, changes, or circumstances.
• The proposed transaction may not close as expected or at all if closing conditions are not met or satisfied timely.
• The outcome of any legal proceedings instituted against Strive, Semler Scientific, or the combined company could be adverse.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all, partly due to risks associated with Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws, and regulations, and their enforcement, could negatively impact the transaction's benefits.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The transaction may be more expensive or take longer to complete than expected.
• Management's attention may be diverted from ongoing business operations.
• Dilution of Strive's Class A common stock may occur due to additional share issuance.
• Potential adverse reactions from customers or changes to business or employee relationships could arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could impact the transaction.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The proposed business combination is expected to generate strategic and financial benefits, including anticipated cost savings and strategic gains, and positively impact the combined company's future financial performance. However, these forward-looking statements are subject to significant risks and uncertainties, including those related to integration challenges, unexpected costs, and broader economic and market conditions.

Management Comments

• Management believes that expectations regarding forward-looking statements are based upon reasonable assumptions within the bounds of existing knowledge of business and operations.
• Management acknowledges there can be no assurance that actual results will not differ materially from any projected future results expressed or implied by forward-looking statements.

Industry Context

The filing highlights risks associated with 'Bitcoin treasury strategies and other digital assets,' indicating that at least one of the companies involved in the merger (likely Semler Scientific, given its public stance on Bitcoin) is engaged in or considering digital asset strategies. This aligns with a broader industry trend of companies exploring or adopting digital assets for treasury management or investment purposes, introducing new opportunities but also unique risks.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Stakeholder Impact

• Potential adverse reactions from customers of Strive or Semler Scientific.
• Possible changes to business or employee relationships due to the proposed transaction.
• Dilution for existing shareholders of Strive's Class A common stock due to new share issuance.

Next Steps

• Strive and Semler Scientific will continue to file relevant documents with the SEC concerning the proposed transaction.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any amendments or supplements.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury, Digital Assets, Corporate Governance, Proxy Solicitation